| Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome D Rossi, V Spina, M Cerri, S Rasi, C Deambrogi, L De Paoli, L Laurenti, ... Clinical Cancer Research 15 (13), 4415-4422, 2009 | 257 | 2009 |
| Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of … M Thorsélius, A Kröber, F Murray, U Thunberg, G Tobin, A Bühler, ... Blood 107 (7), 2889-2894, 2006 | 245 | 2006 |
| Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia V Audrito, S Serra, D Brusa, F Mazzola, F Arruga, T Vaisitti, M Coscia, ... Blood, The Journal of the American Society of Hematology 125 (1), 111-123, 2015 | 190 | 2015 |
| Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study R Bomben, M Dal Bo, D Capello, F Forconi, R Maffei, L Laurenti, D Rossi, ... British journal of haematology 144 (4), 492-506, 2009 | 152 | 2009 |
| The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation R Maffei, J Bulgarelli, S Fiorcari, L Bertoncelli, S Martinelli, C Guarnotta, ... haematologica 98 (7), 1115, 2013 | 134 | 2013 |
| Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis F Cavazzini, JA Hernandez, A Gozzetti, A Russo Rossi, C De Angeli, ... British journal of haematology 142 (4), 529-537, 2008 | 126 | 2008 |
| MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia L De Paoli, M Cerri, S Monti, S Rasi, V Spina, A Bruscaggin, M Greco, ... Leukemia & lymphoma 54 (5), 1087-1090, 2013 | 121 | 2013 |
| Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia S Fiorcari, R Maffei, V Audrito, S Martinelli, E Ten Hacken, P Zucchini, ... Oncotarget 7 (40), 65968, 2016 | 110 | 2016 |
| The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells S Fiorcari, WS Brown, BW McIntyre, Z Estrov, R Maffei, S O’Brien, ... PloS one 8 (12), e83830, 2013 | 110 | 2013 |
| Comprehensive characterization of IGHV3-21–expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study R Bomben, M Dal Bo, D Capello, D Benedetti, D Marconi, A Zucchetto, ... Blood 109 (7), 2989-2998, 2007 | 87 | 2007 |
| Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib R Maffei, S Fiorcari, S Martinelli, L Potenza, M Luppi, R Marasca Journal of hematology & oncology 8, 1-13, 2015 | 70 | 2015 |
| Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia R Maffei, S Martinelli, R Santachiara, D Rossi, C Guarnotta, E Sozzi, ... Blood, The Journal of the American Society of Hematology 116 (4), 584-592, 2010 | 66 | 2010 |
| Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF R Maffei, S Martinelli, I Castelli, R Santachiara, P Zucchini, M Fontana, ... Leukemia research 34 (3), 312-321, 2010 | 65 | 2010 |
| Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features R Bomben, M Dal-Bo, D Benedetti, D Capello, F Forconi, D Marconi, ... Clinical Cancer Research 16 (2), 620-628, 2010 | 64 | 2010 |
| Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia S Fiorcari, S Martinelli, J Bulgarelli, V Audrito, P Zucchini, E Colaci, ... haematologica 100 (2), 253, 2015 | 56 | 2015 |
| Physical contact with endothelial cells through β1-and β2-integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a … R Maffei, S Fiorcari, J Bulgarelli, S Martinelli, I Castelli, S Deaglio, ... haematologica 97 (6), 952, 2012 | 54 | 2012 |
| Endothelin-1 Promotes Survival and Chemoresistance in Chronic Lymphocytic Leukemia B Cells through ETA Receptor R Maffei, J Bulgarelli, S Fiorcari, S Martinelli, I Castelli, V Valenti, D Rossi, ... PloS one 9 (6), e98818, 2014 | 53 | 2014 |
| Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone R Marasca, R Maffei, S Martinelli, S Fiorcari, J Bulgarelli, G Debbia, ... Hematological Oncology 31 (2), 88-95, 2013 | 48 | 2013 |
| Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status R Marasca, R Maffei, P Zucchini, I Castelli, A Saviola, S Martinelli, ... Leukemia 20 (1), 103-114, 2006 | 46 | 2006 |
| Circulating endothelial cells in patients with chronic lymphocytic leukemia: Clinical‐prognostic and biologic significance GM Rigolin, R Maffei, L Rizzotto, M Ciccone, O Sofritti, G Daghia, F Cibien, ... Cancer 116 (8), 1926-1937, 2010 | 45 | 2010 |
